Who is sponsoring NCT06246682?

NCT06246682 is sponsored by Sohag University.

What drugs are being tested in NCT06246682?

Interventions in NCT06246682: Transcanal Endoscopic removal of atticoantral cholesteatoma.

What condition does NCT06246682 study?

NCT06246682 studies Cholesteatoma of Attic, Cholesteatoma, Middle Ear.

Is NCT06246682 still recruiting?

NCT06246682 is currently status unknown. Last updated 7 February 2024.

Last reviewed 2024-02-07 · How we verify

NCT06246682

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Mastoid Condition on Results of Endoscopic Management of Cholesteatoma

Status unknown NA Last updated 7 February 2024

What this trial tests

NA trial testing Transcanal Endoscopic removal of atticoantral cholesteatoma in Cholesteatoma of Attic in 25 participants. Status unknown.

Timeline

10 February 2024

Primary endpoint
10 December 2025

22 March 2026

Quick facts

Lead sponsor	Sohag University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	25
Start date	10 February 2024
Primary completion	10 December 2025
Estimated completion	22 March 2026
Sites	1 location across Egypt

Drugs / interventions tested

Transcanal Endoscopic removal of atticoantral cholesteatoma

Conditions studied

Cholesteatoma of Attic — all drugs for Cholesteatoma of Attic →
Cholesteatoma, Middle Ear — all drugs for Cholesteatoma, Middle Ear →

Sponsor

Sohag University

Who can join

12 and older, any sex, with Cholesteatoma of Attic or Cholesteatoma, Middle Ear. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this interventional study is to learn about the effect of mastoid process status and the method of ossicular reconstruction on the results of the procedure transcanal endoscopic management of patients with localized atticoantral cholesteatoma

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06246682 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 7 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06246682.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing